Takeda Pharmaceutical Company Limited
Treatment of CNS conditions

Abstract:

Aspects of the present invention relate to a method of treating an epileptic encephalopathy in a mammal in need thereof, comprising administering a composition comprising an effective amount of (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl)methanone or a pharmaceutically acceptable salt thereof to the mammal.